[1] SINGAL P, LI T M, KUMAR D et al. Adriamycin-induced heart failure: mechanisms and modulation[J]. Mol. Cell. Biochem., 207, 77-86(2000).

[2] GILLET J P, GOTTESMAN M M. Mechanisms of multidrug resistance in cancer[J]. Methods. Mol. Biol., 596, 47-76(2010).

[3] PERSIDIS A. Cancer multidrug resistance[J]. Nat. Biotechnol., 17, 94-95(1999).

[4] PEER D, KARP J M, HONG S et al. Nanocarriers as an emerging platform for cancer therapy[J]. Nat. Nanotech., 2, 751-760(2007).

[5] MALTZAHM G V, PARK J H, LIN K Y et al. Nanoparticles that communicate in vivo to amplify tumour targeting[J]. Nat. Mater., 10, 545-552(2011).

[6] ASHLEY C E, CARNES E C, PHILLIPS G K et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers[J]. Nat. Mater., 10, 389-397(2011).

[7] CHEN Y, TAN C, ZHANG H et al. Two-dimensional graphene analogues for biomedical applications[J]. Chem. Soc. Rev., 44, 2681-2701(2015).

[8] CHIMENE D, ALGE D L, GAHARWAR A K. Two-dimensional nanomaterials for biomedical applications: emerging trends and future prospects[J]. Adv. Mater., 27, 7261-7284(2015).

[9] WU J, ZHU Y J, CHEN F. Ultrathin calcium silicate hydrate nanosheets with large specific surface areas: synthesis, crystallization, layered self-assembly and applications as excellent adsorbents for drug, protein, and metal ions[J]. Small, 9, 2911-2925(2013).

[10] EISENBARTH S C, COLEGIO O R, JR W O C et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants[J]. Nature, 453, 1122-1126(2008).

[11] FLACH T L, NG G, HARI A et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity[J]. Nat. Med., 17, 479-487(2011).

[12] MARICHAL T, OHATA K, BEDORET D et al. DNA released from dying host cells mediates aluminum adjuvant activity[J]. Nat. Med., 17, 996-1002(2011).

[13] LI X, WANG X P, ITO A. Tailoring inorganic nanoadjuvants towards next-generation vaccines[J]. Chem. Soc. Rev., 47, 4954-4980(2018).

[14] SUN B, JI Z, LIAO Y P et al. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles[J]. ACS Nano., 7, 10834-10849(2013).

[15] CAI W, YU J, MANN S. Template-free hydrothermal fabrication of hierarchically organized γ-AlOOH hollow microspheres[J]. Micro. Meso. Mater., 122, 42-47(2009).

[16] LI G, GUAN L, LIU Y et al. Template-free solvothermal synthesis of 3D hierarchical nanostructured boehmite assembled by nanosheets[J]. J. Phys. Chem. Solids., 73, 1055-1060(2012).

[17] WANG X P, LI X, SOGO Y et al. Simple synthesis route of mesoporous AlOOH nanofibers to enhance immune responses[J]. RSC. Adv., 3, 8164-8167(2013).

[18] WEN J R, LIU M H, MOU C Y. Synthesis of curtain-like crumpled boehmite and γ-alumina nanosheets[J]. CrystEngComm., 17, 1959-1967(2015).

[19] HICKS R W, PINNAVAIA T J. Nanoparticle assembly of mesoporous AlOOH (Boehmite)[J]. Chem. Mater., 15, 78-82(2003).

[20] LI X, WANG X, HUA Z et al. One-pot synthesis of magnetic and mesoporous bioactive glass composites and their sustained drug release property[J]. Acta. Mater., 56, 3260-3265(2008).

[21] BARRETO J A, O’MALLEY W, KUBEIL M et al. Nanomaterials: applications in cancer imaging and therapy[J]. Adv. Mater., 23, H18-H40(2011).

[22] BILDSTEIN L, DUBERNET C, COUVREUR P. Prodrug-based intracellular delivery of anticancer agents[J]. Adv. Drug. Delivery. Rev., 63, 3-23(2011).

[23] SKOVSGAARD T, NISSEN N I. Membrane transport of anthracyclines[J]. Pharmacol. Therapeut., 18, 293-311(1982).

[24] LI X, WANG X, SOGO Y et al. Mesoporous silica-calcium phosphate- tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy[J]. Adv. Healthcare. Mater., 2, 863-871(2013).

[25] BLOEBAUM R D, LUNDEEN G A, BACHUS K N et al. Dissolution of particulate hydroxyapaptite in a macrophage organelle model[J]. J. Biomed. Mater. Res., 40, 104-114(1998).